PubMed · 2002 · 301 citations · 17 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial EpidemiologyBacterial InfectionsCarbapenem ResistanceMolecular Epidemiology Of ResistanceAcinetobacter Baumannii InfectionAcinetobacter Baumannii ResistanceCarbapenem AntibioticsCarbapenem-nonsusceptible IsolatesEpidemiology Of Bacterial InfectionsGram-negative Bacterial InfectionsMolecular Typing Of Resistant IsolatesPseudomonas Aeruginosa Resistance
BACKGROUND: Carbapenems are important agents for treating nosocomial gram-negative infections. Carbapenem-resistant bacteria have become increasingly problematic in certain regions. This study determined the citywide prevalence and molecular epidemiological features of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY. METHODS: All unique patient isolates of A baumannii and P aeruginosa were collected from 15 Brooklyn hospitals from July 1, 1999, through September 30, 1999. Antibiotic susceptibilities, the genetic relatedness of resistant isolates, and the relationship between antibiotic use and resistance rates were determined. RESULTS: A total of 419 isolates of A baumannii and 823 isolates of P aeruginosa were collected. For A baumannii, 53% were resistant to meropenem and/or imipenem, and 12% were resistant to all standard antibiotics. Ribotyping revealed that a single clone accounted for 62% of the samples and was isolated from patients at all 15 hospitals. The rate of carbapenem resistance was associated with cephalosporin use at each hospital (P =.004). For P aeruginosa, 24% were resistant to imipenem, 5% to amikacin, and 15% to 29% to other antipseudomonal agents. Ribotyping revealed that 3 clones accounted for nearly half of the isolates and were shared by most hospitals. CONCLUSIONS: Approximately 400 patients were infected or colonized with carbapenem-resistant A baumannii and P aeruginosa during a 3-month period in 1999. A few strains have spread widely throughout hospitals in this region. The prevalence of resistant A baumannii seems to be correlated with cephalosporin use. Multiresistant hospital-acquired bacteria should be viewed as a serious public health issue rather than an individual hospital's problem. An intensive coordinated effort will be needed to effectively address this problem.
17
V. M. Manikal, David Landman, Guillermo Saurina et al. · Clinical Infectious Diseases · 2000 · 310 citations · Full text
Maria Letizia Riccio, Nicola Franceschini, Letizia Boschi et al. · Antimicrobial Agents and Chemotherapy · 2000 · 242 citations · Full text
Germán Bou, Gonzalo Cerveró, M.Á. Domínguez et al. · Journal of Clinical Microbiology · 2000 · 238 citations · Full text